J&J recall 9m more Tylenol bottles

Related tags Mcneil laboratories

Johnson & Johnson is recalling a further 9m Tylenol bottles in the US after learning of inconsistencies in product label warnings.

The drugmaker said it failed to sufficiently alert customers about the presence of trace amounts of alcohol in product flavourings in three brands of Tylenol Cold Multi-Symptom Liquid.

J&J’s latest Tylenol recall involves its Daytime 8-ounce Citrus Burst, Severe 8-Ounce Cool Burst and Night time 8-Ounce Cool Burst products.

“There is less than one per cent alcohol in the flavouring, and this information is on the back of the bottles,”​ said spokesperson Bonnie Jacobs on the J&J website. “But the information does not appear on the front of the bottles,”​ she added.

J&J said the recalled products present no risk to public health and encourages consumers to continue using its Tylenol drug as as no side-effects have been reported.

The recalls were made at the McNeil Consumer Healthcare unit in Fort Washington, US, which was closed by the FDA in 2010 after it reported unsanitary conditions for drug-making and lapses in quality control.

The plant is not expected to recommence operations until the end of next year.

Related topics Markets & Regulations QA/QC

Related news

Show more

Related product

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Follow us

Products

View more

Webinars